Aberdeen Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Aberdeen Group’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-120,744	Closed	-$759K	–	944
2019 Q1	$759K	Buy	+120,744	New	+$846K	﹤0.01%	835

Other funds holding NPTN

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Aberdeen Group's NPTN Position: Q2 2019 in Review

Aberdeen Group sold out of NEOPHOTONICS CORP (NPTN) in Q2 2019, closing a stake of 120,744 shares — an estimated $759K sold.

Aberdeen Group first reported a position in NPTN in Q1 2019 and held it in 1 quarter. The position peaked at $759K in Q1 2019. 113 funds tracked by Wall St. Rank hold NPTN as of Q2 2019.

Aberdeen Group reported no remaining NEOPHOTONICS CORP position as of Q2 2019 after selling out during the quarter.
Aberdeen Group sold 120,744 NEOPHOTONICS CORP shares in Q2 2019, an estimated $759K.
Aberdeen Group first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 1 quarter.
Aberdeen Group's NEOPHOTONICS CORP position peaked at $759K in Q1 2019.
113 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2019.

Based on Aberdeen Group's 13F filing for Q2 2019, filed 13 Aug 2019.